These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 27015777)

  • 1. Oral Isotretinoin: New Developments Relevant to Clinical Practice.
    Tan J; Boyal S; Desai K; Knezevic S
    Dermatol Clin; 2016 Apr; 34(2):175-84. PubMed ID: 27015777
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of Evidence for Acne Remission With Oral Isotretinoin Cumulative Dosing of 120-150 mg/kg.
    Tan J; Knezevic S; Boyal S; Waterman B; Janik T
    J Cutan Med Surg; 2016 Jan; 20(1):13-20. PubMed ID: 26187395
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combination of low-dose isotretinoin and pulsed oral azithromycin for maximizing efficacy of acne treatment.
    Hasibur MR; Meraj Z
    Mymensingh Med J; 2013 Jan; 22(1):42-8. PubMed ID: 23416807
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-dose isotretinoin treatment and the rate of retrial, relapse, and adverse effects in patients with acne vulgaris.
    Blasiak RC; Stamey CR; Burkhart CN; Lugo-Somolinos A; Morrell DS
    JAMA Dermatol; 2013 Dec; 149(12):1392-8. PubMed ID: 24173086
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of clinical efficacy, side effects, and laboratory changes among patients with acne vulgaris receiving single versus twice daily dose of oral isotretinoin.
    Ahmad HM
    Dermatol Ther; 2015; 28(3):151-7. PubMed ID: 25754162
    [TBL] [Abstract][Full Text] [Related]  

  • 6. On isotretinoin dosing, adverse effects, and efficacy.
    Berk DR
    Australas J Dermatol; 2011 May; 52(2):147-8; author reply 148. PubMed ID: 21605103
    [No Abstract]   [Full Text] [Related]  

  • 7. Assessment of the efficacy and safety of a combination of 2 topical retinoids (RetinSphere) in maintaining post-treatment response of acne to oral isotretinoin.
    Truchuelo MT; Jiménez N; Mavura D; Jaén P
    Actas Dermosifiliogr; 2015 Mar; 106(2):126-32. PubMed ID: 25306870
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the efficacies of intermittent and continuous low-dose isotretinoin regimens in the treatment of moderate acne vulgaris.
    Boyraz N; Mustak PK
    Int J Dermatol; 2013 Oct; 52(10):1265-7. PubMed ID: 23675954
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low-dose schema of isotretinoin in acne vulgaris.
    Mandekou-Lefaki I; Delli F; Teknetzis A; Euthimiadou R; Karakatsanis G
    Int J Clin Pharmacol Res; 2003; 23(2-3):41-6. PubMed ID: 15018017
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of acne with oral isotretinoin in patients with cystic fibrosis.
    Perera E; Massie J; Phillips RJ
    Arch Dis Child; 2009 Aug; 94(8):583-6. PubMed ID: 19465582
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effectiveness of conventional, low-dose and intermittent oral isotretinoin in the treatment of acne: a randomized, controlled comparative study.
    Lee JW; Yoo KH; Park KY; Han TY; Li K; Seo SJ; Hong CK
    Br J Dermatol; 2011 Jun; 164(6):1369-75. PubMed ID: 21114478
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of continuous high versus low dose oral isotretinoin regimens on dermcidin expression in patients with moderate to severe acne vulgaris.
    El Aziz Ragab MA; Omar SS; Collier A; El-Wafa RAHA; Gomaa N
    Dermatol Ther; 2018 Nov; 31(6):e12715. PubMed ID: 30397984
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Isotretinoin: dose, duration and relapse. What does 30 years of usage tell us?
    Rademaker M
    Australas J Dermatol; 2013 Aug; 54(3):157-62. PubMed ID: 23013115
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral isotretinoin for acne, adjusting treatment according to patient's response.
    Ghaffarpour G; Mazloomi S; Soltani-Arabshahi R; Seyed KS
    J Drugs Dermatol; 2006 Oct; 5(9):878-82. PubMed ID: 17039654
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is oral isotretinoin the treatment of choice in moderate and severe inflammatory acne vulgaris?
    Verros CD; Rallis E
    J Eur Acad Dermatol Venereol; 2007 Oct; 21(9):1270-1. PubMed ID: 17894728
    [No Abstract]   [Full Text] [Related]  

  • 16. Isotretinoin dosing: past, present, and future trends.
    Hirsch RJ; Shalita AR
    Semin Cutan Med Surg; 2001 Sep; 20(3):162-5. PubMed ID: 11594671
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-dose isotretinoin in acne vulgaris: improved treatment outcomes and quality of life.
    Cyrulnik AA; Viola KV; Gewirtzman AJ; Cohen SR
    Int J Dermatol; 2012 Sep; 51(9):1123-30. PubMed ID: 22909370
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effectiveness of conventional, low-dose and intermittent oral isotretinoin in the treatment of acne: a randomized, controlled comparative study: comment.
    Berk DR
    Br J Dermatol; 2011 Jul; 165(1):205. PubMed ID: 21410669
    [No Abstract]   [Full Text] [Related]  

  • 19. Acute acne flare following isotretinoin administration: potential protective role of low starting dose.
    Borghi A; Mantovani L; Minghetti S; Virgili A; Bettoli V
    Dermatology; 2009; 218(2):178-80. PubMed ID: 19060474
    [No Abstract]   [Full Text] [Related]  

  • 20. Systemic therapy for acne vulgaris.
    Layton AM
    Hosp Med; 2004 Feb; 65(2):80-5. PubMed ID: 14997773
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.